Prognostic implications of circulating tumor cells (CTCs) after neoadjuvant chemotherapy for triple negative breast cancer (TNBC)

C. Hall; K. R. Hess; L. Ravenberg; A. Clayborn; G. M. Rauch; R. Candelaria; E. A. Mittendorf; S. L. Moulder; A. Thompson; A. Lucci

doi:10.1093/annonc/mdy270.220

Prognostic implications of circulating tumor cells (CTCs) after neoadjuvant chemotherapy for triple negative breast cancer (TNBC)

C. Hall, K. R. Hess, L. Ravenberg, A. Clayborn, G. M. Rauch, R. Candelaria, E. A. Mittendorf, S. L. Moulder, A. Thompson, A. Lucci

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	viii72
Journal	Annals of oncology : official journal of the European Society for Medical Oncology
Volume	29
DOIs	https://doi.org/10.1093/annonc/mdy270.220
State	Published - Oct 1 2018

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1093/annonc/mdy270.220

Cite this

Hall, C., Hess, K. R., Ravenberg, L., Clayborn, A., Rauch, G. M., Candelaria, R., Mittendorf, E. A., Moulder, S. L., Thompson, A., & Lucci, A. (2018). Prognostic implications of circulating tumor cells (CTCs) after neoadjuvant chemotherapy for triple negative breast cancer (TNBC). Annals of oncology : official journal of the European Society for Medical Oncology, 29, viii72. https://doi.org/10.1093/annonc/mdy270.220

Hall, C, Hess, KR, Ravenberg, L, Clayborn, A, Rauch, GM , Candelaria, R, Mittendorf, EA, Moulder, SL, Thompson, A & Lucci, A 2018, 'Prognostic implications of circulating tumor cells (CTCs) after neoadjuvant chemotherapy for triple negative breast cancer (TNBC)', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 29, pp. viii72. https://doi.org/10.1093/annonc/mdy270.220

@article{7fab7dfb383c44f48ea97f3ae664d694,

title = "Prognostic implications of circulating tumor cells (CTCs) after neoadjuvant chemotherapy for triple negative breast cancer (TNBC)",

author = "C. Hall and Hess, {K. R.} and L. Ravenberg and A. Clayborn and Rauch, {G. M.} and R. Candelaria and Mittendorf, {E. A.} and Moulder, {S. L.} and A. Thompson and A. Lucci",

year = "2018",

month = oct,

day = "1",

doi = "10.1093/annonc/mdy270.220",

language = "English (US)",

volume = "29",

pages = "viii72",

journal = "Annals of oncology : official journal of the European Society for Medical Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - Prognostic implications of circulating tumor cells (CTCs) after neoadjuvant chemotherapy for triple negative breast cancer (TNBC)

AU - Hall, C.

AU - Hess, K. R.

AU - Ravenberg, L.

AU - Clayborn, A.

AU - Rauch, G. M.

AU - Candelaria, R.

AU - Mittendorf, E. A.

AU - Moulder, S. L.

AU - Thompson, A.

AU - Lucci, A.

PY - 2018/10/1

Y1 - 2018/10/1

UR - http://www.scopus.com/inward/record.url?scp=85081530713&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85081530713&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdy270.220

DO - 10.1093/annonc/mdy270.220

M3 - Article

C2 - 32137991

SN - 0923-7534

VL - 29

SP - viii72

JO - Annals of oncology : official journal of the European Society for Medical Oncology

JF - Annals of oncology : official journal of the European Society for Medical Oncology

ER -

Prognostic implications of circulating tumor cells (CTCs) after neoadjuvant chemotherapy for triple negative breast cancer (TNBC)

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this